MedTrace Logo

Line Versus Spot Ablation in Persistent Atrial Fibrillation

NCT00196157 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2009-05-29

No results posted yet for this study

Summary

In this randomized study dealing with the ablative treatment of persistent atrial fibrillation, two ablation strategies are compared: a more anatomically guided linear ablation scheme versus an electrophysiological guided focal ablation strategy aiming at the electrical isolating of the pulmonary veins and ablating areas of fragmented intracardiac electrograms thought to maintain atrial fibrillation.

Conditions

Interventions

PROCEDURE

linear anatomically oriented ablations

linear lesions to ablate persistent atrial fibrillation

PROCEDURE

focal electrophysiological oriented ablations

focal electrophysiologically guided ablations to treat persistent atrial fibrillation

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Claus Schmitt, MD · Deutsches Herzzentrum Muenchen

  • Heidi Estner, MD · Deutsches Herzzentrum Muenchen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2008-05-31
Completion
2008-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196157 on ClinicalTrials.gov